Welcome to Multibagg AI
Log in to access personalized features
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Upcoming Result Date: May 28, 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
MK Proteins Limited is a company engaged in the manufacturing and trading of edible oils, based in Haryana, India.
The company specializes in refining crude oils to produce various products like Refined Rice Bran Oil, Canola Oil, and Sunflower Oil.
MK Proteins has significantly expanded its production capacity from 120 TPD to 250 TPD over the years.
The company leverages mechanized refineries to produce high-quality oils free from impurities.
In 2017, MK Proteins raised significant capital through a public issue to further its business operations.
Agricultural Food & other Products
Edible Oil
190 Cr
High Risk
22.3
35.5
-0.9
2.6
9.75
3.80
Sales CAGR
Profit CAGR
ROE
ROCE
Bearish
4
Neutral
7
Bullish
3
Bearish
33
Neutral
7
Bullish
6
Bearish
29
Neutral
0
Bullish
3
Discovery themes featuring this stock
M K Proteins Ltd (MKPL) is currently trading at 5.05 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
MK Proteins Limited is a company engaged in the manufacturing and trading of edible oils, based in Haryana, India. The company specializes in refining crude oils to produce various products like Refined Rice Bran Oil, Canola Oil, and Sunflower Oil. MK Proteins has significantly expanded its production capacity from 120 TPD to 250 TPD over the years. The company leverages mechanized refineries to produce high-quality oils free from impurities. In 2017, MK Proteins raised significant capital through a public issue to further its business operations.
Over the past 52 weeks, M K Proteins Ltd has traded between a low of ₹3.80 and a high of ₹9.75. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
M K Proteins Ltd has a market capitalization of approximately 189.56. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
M K Proteins Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 22.33 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 189.56 Cr, M K Proteins Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
M K Proteins Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of M K Proteins Ltd is 22.33. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
224.99 | 280 Cr | 67.43 | 1.88 | 0.15 | 3.22 | 12.68 | 0.73 | ||
136.70 | 256 Cr | 1065.88 | 7.13 | 0.00 | 1.63 | 2.17 | 0.84 | ||
592.30 | 190 Cr | 12.38 | 0.54 | 0.00 | 4.97 | 7.64 | 3.48 | ||
5.05 | 190 Cr | 22.33 | 2.57 | 0.00 | 11.44 | 17.16 | 10.61 | ||
23.50 | 188 Cr | 12.87 | 1.13 | 0.00 | 13.20 | 19.81 | 5.55 | ||
183.00 | 106 Cr | 15.12 | 2.84 | 0.00 | 21.50 | 21.01 | 10.01 | ||
44.00 | 92 Cr | 12.69 | 2.18 | 0.00 | 11.16 | 13.84 | 13.47 | ||
| Median: 7 Co. | — | 136.70 | 190 Cr | 15.12 | 2.18 | 0.00 | 11.16 | 13.84 | 5.55 |
Board Meeting / Results
Board meeting on 29 May 2026 to consider and approve audited financial results for the quarter and year ended 31 Mar 2026; re-appointment of cost and internal auditors for FY2026-27; trading window to reopen 48 hrs after results.
Board Meeting - Audited Results
Board meeting scheduled for 29 May 2026 to consider and approve audited financial results for quarter and year ended 31 Mar 2026, re-appoint cost and internal auditors for FY2026-27, and other business; trading window to reopen 48 hrs after results.
